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st International Congress on Neurobiology and Clinical Psychopharmacology and European
Psychiatric Association Conference on Treatment Guidance
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The World Federation of Societies of Biological Psychia-
try (WFSBP) has developed several drug treatment
guidelines. The following guidelines have either been
published already or will be published soon [1-8]
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